Gilead Sciences snares Roche veteran O'Day as CEO

Drugmaker Gilead Sciences Inc on Monday named Roche Holding AG's Daniel O'Day as its new chief executive, tapping an industry veteran to fill a management vacuum.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Health